Year To Quarter End Consolidated Statement Of Comprehensive Income

Tri Chemical Laboratories Inc. - Filing #7340286

Concept 2023-02-01 to
2024-01-31
2023-02-01 to
2024-01-31
2023-02-01 to
2024-01-31
2023-02-01 to
2024-01-31
2023-02-01 to
2024-01-31
2022-02-01 to
2023-01-31
2022-02-01 to
2023-01-31
2022-02-01 to
2023-01-31
2022-02-01 to
2023-01-31
2022-02-01 to
2023-01-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
4,250,242,000 JPY
4,250,242,000 JPY
4,250,242,000 JPY
2,470,625,000 JPY
4,250,242,000 JPY
6,557,139,000 JPY
6,557,139,000 JPY
4,832,417,000 JPY
6,557,139,000 JPY
6,557,139,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
7,883,000 JPY
3,756,000 JPY
Foreign currency translation adjustment
126,692,000 JPY
-11,498,000 JPY
Remeasurements of defined benefit plans, net of tax
1,431,000 JPY
567,000 JPY
Share of other comprehensive income of entities accounted for using equity method
62,629,000 JPY
380,664,000 JPY
Other comprehensive income
198,637,000 JPY
373,489,000 JPY
Comprehensive income
2,669,263,000 JPY
5,205,907,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,669,263,000 JPY
5,205,907,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.